products coa

Product Name

HGH

CAS#:12629-01-5

Sizes Select one specification

10iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812368::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNjgucGRm||||||12iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812369::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNjkucGRm||||||15iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812370::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzAucGRm||||||20iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812371::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzEucGRm||||||24iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812372::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzIucGRm||||||36iu::::::Literature-based research context for laboratory reference only.::::::Human Growth Hormone (HGH) is a protein-based peptide hormone produced by the anterior pituitary gland. First isolated in 1956, it plays a central role in growth, metabolism, and body composition. Research has investigated HGH in the context of cellular regeneration, lean mass maintenance, and metabolic regulation.::::::Raben, 1958, Journal of Clinical Endocrinology and Metabolism.::::::1812373::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzMucGRm

Lot Number

Product Name

ss-31

CAS#:736992-21-5

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide developed at Cornell University. Research has focused on its ability to bind cardiolipin on the inner mitochondrial membrane, stabilizing mitochondrial structure and improving bioenergetics in aged or damaged tissues.::::::Szeto, 2014, British Journal of Pharmacology.::::::1812374::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzQucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide developed at Cornell University. Research has focused on its ability to bind cardiolipin on the inner mitochondrial membrane, stabilizing mitochondrial structure and improving bioenergetics in aged or damaged tissues.::::::Szeto, 2014, British Journal of Pharmacology.::::::1812375::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzUucGRm||||||50mg::::::Literature-based research context for laboratory reference only.::::::SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide developed at Cornell University. Research has focused on its ability to bind cardiolipin on the inner mitochondrial membrane, stabilizing mitochondrial structure and improving bioenergetics in aged or damaged tissues.::::::Szeto, 2014, British Journal of Pharmacology.::::::1812376::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzYucGRm

Lot Number

Product Name

CJC 1295 no DAC

CAS#:448757-42-6

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::CJC-1295 without DAC is a truncated analogue of growth hormone-releasing hormone (GHRH). It stimulates GH secretion with a shorter half-life than its DAC counterpart, making it suitable for pulsatile GH-release study protocols.::::::Merriam et al., 2001, Endocrine Reviews.
~Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism.::::::1812377::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzcucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::CJC-1295 without DAC is a truncated analogue of growth hormone-releasing hormone (GHRH). It stimulates GH secretion with a shorter half-life than its DAC counterpart, making it suitable for pulsatile GH-release study protocols.::::::Merriam et al., 2001, Endocrine Reviews.
~Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism.::::::1812378::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzgucGRm

Lot Number

Product Name

CJC 1295 whit DAC

CAS#:863288-34-0

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::CJC-1295 with DAC incorporates a Drug Affinity Complex (DAC) that binds to serum albumin, dramatically extending its half-life to 6–8 days. Researchers use it to study sustained growth hormone secretion and its downstream anabolic and metabolic effects.::::::Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism.::::::1812379::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNzkucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::CJC-1295 with DAC incorporates a Drug Affinity Complex (DAC) that binds to serum albumin, dramatically extending its half-life to 6–8 days. Researchers use it to study sustained growth hormone secretion and its downstream anabolic and metabolic effects.::::::Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism.::::::1812380::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODAucGRm

Lot Number

Product Name

CJC1295(without DAC)+IPA

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number

Product Name

Melanotan Ⅰ

CAS#:75921-69-6

Sizes Select one specification

Lot Number

Product Name

Melanotan Ⅱ

CAS#:121062-08-6

Sizes Select one specification

Lot Number

Product Name

KPV

CAS#:67727-97-3

Sizes Select one specification

Lot Number

Product Name

Sermorelin

CAS#:86168-78-7

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Sermorelin is a 29-amino-acid synthetic analogue of endogenous GHRH. Historically approved for GH deficiency diagnosis, it is widely used to assess pituitary GH reserve and study hypothalamic-pituitary axis biology.::::::Merriam et al., 2001, Endocrine Reviews.::::::1812385::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODUucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Sermorelin is a 29-amino-acid synthetic analogue of endogenous GHRH. Historically approved for GH deficiency diagnosis, it is widely used to assess pituitary GH reserve and study hypothalamic-pituitary axis biology.::::::Merriam et al., 2001, Endocrine Reviews.::::::1812386::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODYucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Sermorelin is a 29-amino-acid synthetic analogue of endogenous GHRH. Historically approved for GH deficiency diagnosis, it is widely used to assess pituitary GH reserve and study hypothalamic-pituitary axis biology.::::::Merriam et al., 2001, Endocrine Reviews.::::::1812387::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODcucGRm

Lot Number

Product Name

Tesamorelin

CAS#:218949-48-5

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Tesamorelin is a stabilized GHRH analogue with a trans-3-hexenoic acid modification conferring resistance to DPP-IV cleavage. Research has focused on its selective GH-releasing properties and effects on visceral adipose tissue reduction.::::::Falutz et al., 2010, New England Journal of Medicine.::::::1812388::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODgucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Tesamorelin is a stabilized GHRH analogue with a trans-3-hexenoic acid modification conferring resistance to DPP-IV cleavage. Research has focused on its selective GH-releasing properties and effects on visceral adipose tissue reduction.::::::Falutz et al., 2010, New England Journal of Medicine.::::::1812389::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzODkucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Tesamorelin is a stabilized GHRH analogue with a trans-3-hexenoic acid modification conferring resistance to DPP-IV cleavage. Research has focused on its selective GH-releasing properties and effects on visceral adipose tissue reduction.::::::Falutz et al., 2010, New England Journal of Medicine.::::::1812390::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTAucGRm

Lot Number

Product Name

IGF-1LR3

CAS#:946870-92-4

Sizes Select one specification

Lot Number

Product Name

L-carnitine 600mg

CAS#:541-15-1

Sizes Select one specification

Lot Number

Product Name

Epitalon

CAS#:307297-39-8

Sizes Select one specification

10mg::::::Literature-based research context for laboratory reference only.::::::Epitalon (Epithalon) is a synthetic tetrapeptide corresponding to the active region of epithalamin, a pineal gland extract isolated by Vladimir Khavinson. Research has examined its telomerase-activating properties and role in regulating circadian rhythms and antioxidant enzyme expression.::::::Khavinson et al., 2003, Neuro Endocrinology Letters.::::::1812394::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTQucGRm||||||50mg::::::Literature-based research context for laboratory reference only.::::::Epitalon (Epithalon) is a synthetic tetrapeptide corresponding to the active region of epithalamin, a pineal gland extract isolated by Vladimir Khavinson. Research has examined its telomerase-activating properties and role in regulating circadian rhythms and antioxidant enzyme expression.::::::Khavinson et al., 2003, Neuro Endocrinology Letters.::::::1812395::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTUucGRm

Lot Number

Product Name

Ipamorelin

CAS#:170851-70-4

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Ipamorelin is a pentapeptide ghrelin receptor agonist developed by Novo Nordisk. It selectively stimulates GH release with minimal effect on cortisol or prolactin, making it a widely used research compound for studying the ghrelin axis and GH secretagogue receptor biology.::::::Raun et al., 1998, European Journal of Endocrinology.::::::1812396::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTYucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Ipamorelin is a pentapeptide ghrelin receptor agonist developed by Novo Nordisk. It selectively stimulates GH release with minimal effect on cortisol or prolactin, making it a widely used research compound for studying the ghrelin axis and GH secretagogue receptor biology.::::::Raun et al., 1998, European Journal of Endocrinology.::::::1812397::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTcucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Ipamorelin is a pentapeptide ghrelin receptor agonist developed by Novo Nordisk. It selectively stimulates GH release with minimal effect on cortisol or prolactin, making it a widely used research compound for studying the ghrelin axis and GH secretagogue receptor biology.::::::Raun et al., 1998, European Journal of Endocrinology.::::::1812398::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTgucGRm

Lot Number

Product Name

Semax

CAS#:80714-61-0

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::Semax is a synthetic heptapeptide derived from the N-terminal fragment of ACTH (4–10). Developed at the Institute of Molecular Genetics in Russia, it has been studied for nootropic, neuroprotective, and BDNF-upregulating properties in ischemia and cognitive function research.::::::Gusev et al., 1997, Neuroscience and Behavioral Physiology.::::::1812399::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzOTkucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Semax is a synthetic heptapeptide derived from the N-terminal fragment of ACTH (4–10). Developed at the Institute of Molecular Genetics in Russia, it has been studied for nootropic, neuroprotective, and BDNF-upregulating properties in ischemia and cognitive function research.::::::Gusev et al., 1997, Neuroscience and Behavioral Physiology.::::::1812400::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDAucGRm||||||30mg::::::Literature-based research context for laboratory reference only.::::::Semax is a synthetic heptapeptide derived from the N-terminal fragment of ACTH (4–10). Developed at the Institute of Molecular Genetics in Russia, it has been studied for nootropic, neuroprotective, and BDNF-upregulating properties in ischemia and cognitive function research.::::::Gusev et al., 1997, Neuroscience and Behavioral Physiology.::::::1812401::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDEucGRm

Lot Number

Product Name

ARA 290

CAS#:1208243-50-8

Sizes Select one specification

Lot Number

Product Name

Kisspeptin-10

CAS#:374675-21-5

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin-54. Acting on KISS1R, it is a potent activator of the HPG axis. Research has examined its role in triggering GnRH pulsatility, puberty onset, and reproductive neuroendocrinology.::::::Seminara et al., 2003, New England Journal of Medicine.::::::1812403::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDMucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin-54. Acting on KISS1R, it is a potent activator of the HPG axis. Research has examined its role in triggering GnRH pulsatility, puberty onset, and reproductive neuroendocrinology.::::::Seminara et al., 2003, New England Journal of Medicine.::::::1812404::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDQucGRm

Lot Number

Product Name

Selank

CAS#:129954-34-3

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::Selank is a synthetic heptapeptide analogue of the endogenous neuropeptide tuftsin. Developed in Russia, it has been investigated for anxiolytic, nootropic, and immunomodulatory effects, with research suggesting interactions with GABAergic and serotonin systems.::::::Kozlovskaya et al., 2003, Bulletin of Experimental Biology and Medicine.::::::1812405::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDUucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Selank is a synthetic heptapeptide analogue of the endogenous neuropeptide tuftsin. Developed in Russia, it has been investigated for anxiolytic, nootropic, and immunomodulatory effects, with research suggesting interactions with GABAergic and serotonin systems.::::::Kozlovskaya et al., 2003, Bulletin of Experimental Biology and Medicine.::::::1812406::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDYucGRm

Lot Number

Product Name

Glutathione

CAS#:70-18-8

Sizes Select one specification

600mg::::::Literature-based research context for laboratory reference only.::::::Glutathione is a tripeptide (γ-glutamyl-cysteinyl-glycine) and the most abundant intracellular antioxidant. Discovered by Frederick Gowland Hopkins in 1921, it is researched for its central role in redox homeostasis, xenobiotic detoxification, and immune modulation.::::::Meister and Anderson, 1983, Annual Review of Biochemistry.::::::1812407::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDcucGRm||||||1500mg::::::Literature-based research context for laboratory reference only.::::::Glutathione is a tripeptide (γ-glutamyl-cysteinyl-glycine) and the most abundant intracellular antioxidant. Discovered by Frederick Gowland Hopkins in 1921, it is researched for its central role in redox homeostasis, xenobiotic detoxification, and immune modulation.::::::Meister and Anderson, 1983, Annual Review of Biochemistry.::::::1812408::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MDgucGRm

Lot Number

Product Name

Snap-8

CAS#:868844-74-0

Sizes Select one specification

Lot Number

Product Name

VIP

CAS#:40077-57-4

Sizes Select one specification

Lot Number

Product Name

PT-141

CAS#:189691-06-3

Sizes Select one specification

Lot Number

Product Name

Lemon Bottle

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number

Product Name

Acetic Acid Water

CAS#:64-19-7

Sizes Select one specification

Lot Number

Product Name

TR

CAS#:2023788-19-2

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812415::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MTUucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812416::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MTYucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812417::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MTcucGRm||||||15mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812418::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MTgucGRm||||||20mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812419::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MTkucGRm||||||30mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812420::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjAucGRm||||||40mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812421::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjEucGRm||||||50mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812422::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjIucGRm||||||60mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812423::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjMucGRm||||||100mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812424::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjQucGRm||||||120mg::::::Literature-based research context for laboratory reference only.::::::TR is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Its twin-incretin pharmacology has generated significant research interest in metabolic disease, covering insulin secretion, glucagon suppression, gastric emptying, and adipose tissue biology.::::::Coskun et al., 2018, Molecular Metabolism.::::::1812425::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjUucGRm

Lot Number

Product Name

Semaglutide

CAS#:910463-68-2

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812426::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjYucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812427::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjcucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812428::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjgucGRm||||||20mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812429::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MjkucGRm||||||30mg::::::Literature-based research context for laboratory reference only.::::::Semaglutide is a GLP-1 receptor agonist with C18 fatty diacid modification enabling albumin binding and a prolonged half-life (~7 days). Research now covers body weight, cardiovascular outcomes, neuroinflammation, and addiction models.::::::Lau et al., 2015, Journal of Medicinal Chemistry.::::::1812430::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzAucGRm

Lot Number

Product Name

RT

CAS#:2381089-83-2

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812431::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzEucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812432::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzIucGRm||||||20mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812433::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzMucGRm||||||30mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812434::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzQucGRm||||||40mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812435::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzUucGRm||||||50mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812436::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzYucGRm||||||60mg::::::Literature-based research context for laboratory reference only.::::::RT (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist. Its tri-agonist mechanism enables research into simultaneous incretin activity and enhanced energy expenditure, making it a leading compound in next-generation metabolic disorder studies.::::::Jastreboff et al., 2023, New England Journal of Medicine.::::::1812437::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzcucGRm

Lot Number

Product Name

Cagrilintide

CAS#:1415456-99-3

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk. Research explores its complementary mechanism to GLP-1 agonism for additive weight reduction, with trials showing enhanced satiety signaling via area postrema and dorsal vagal complex.::::::Enebo et al., 2021, Lancet.
~Lau et al., 2021, Journal of Medicinal Chemistry.::::::1812438::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzgucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk. Research explores its complementary mechanism to GLP-1 agonism for additive weight reduction, with trials showing enhanced satiety signaling via area postrema and dorsal vagal complex.::::::Enebo et al., 2021, Lancet.
~Lau et al., 2021, Journal of Medicinal Chemistry.::::::1812439::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0MzkucGRm

Lot Number

Product Name

Glow(TB+BPC-157+GHK)

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number

Product Name

Klow(TB+BPC-157+GHK+KPV)

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number

Product Name

TB-500

CAS#:77591-33-4

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::TB-500 (Thymosin Beta-4 fragment) is derived from the 17–23 amino acid sequence of thymosin beta-4. Research has focused on actin sequestration, cell migration, angiogenesis, and anti-inflammatory signaling in cardiac, muscle, and ocular tissue models.::::::Goldstein et al., 2012, Annals of the New York Academy of Sciences.::::::1812442::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDIucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::TB-500 (Thymosin Beta-4 fragment) is derived from the 17–23 amino acid sequence of thymosin beta-4. Research has focused on actin sequestration, cell migration, angiogenesis, and anti-inflammatory signaling in cardiac, muscle, and ocular tissue models.::::::Goldstein et al., 2012, Annals of the New York Academy of Sciences.::::::1812443::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDMucGRm

Lot Number

Product Name

BPC-157

CAS#:137525-51-0

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::BPC-157 (Body Protection Compound 157) is a pentadecapeptide sequence derived from human gastric juice protein. Extensively studied since the 1990s, research covers gut healing, tendon and ligament repair, CNS neuroprotection, and dopamine and serotonin system modulation.::::::Sikiric et al., 2018, Current Pharmaceutical Design.::::::1812444::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDQucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::BPC-157 (Body Protection Compound 157) is a pentadecapeptide sequence derived from human gastric juice protein. Extensively studied since the 1990s, research covers gut healing, tendon and ligament repair, CNS neuroprotection, and dopamine and serotonin system modulation.::::::Sikiric et al., 2018, Current Pharmaceutical Design.::::::1812445::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDUucGRm

Lot Number

Product Name

BPC + TB

CAS#:Proprietary Blend

Sizes Select one specification

10mg（5mg/5mg）::::::Literature-based research context for laboratory reference only.::::::BPC+TB is a research blend combining BPC-157 and TB-500. The combination is studied for complementary mechanisms — BPC-157's cytoprotective and neurotrophic effects alongside TB-500's actin-sequestering and angiogenic properties.::::::Sikiric et al., 2018, Current Pharmaceutical Design.
~Goldstein et al., 2012, Annals of the New York Academy of Sciences.::::::1812446::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDYucGRm||||||20mg（10mg/10mg）::::::Literature-based research context for laboratory reference only.::::::BPC+TB is a research blend combining BPC-157 and TB-500. The combination is studied for complementary mechanisms — BPC-157's cytoprotective and neurotrophic effects alongside TB-500's actin-sequestering and angiogenic properties.::::::Sikiric et al., 2018, Current Pharmaceutical Design.
~Goldstein et al., 2012, Annals of the New York Academy of Sciences.::::::::::::

Lot Number

Product Name

NAD+

CAS#:53-84-9

Sizes Select one specification

100mg::::::Literature-based research context for laboratory reference only.::::::NAD+ is a critical coenzyme found in all living cells, serving as an electron carrier in cellular respiration and a substrate for sirtuins and PARPs. Research spans aging biology, DNA repair, mitochondrial function, and neurodegeneration.::::::Canto et al., 2015, Cell Metabolism.::::::1812447::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDcucGRm||||||500mg::::::Literature-based research context for laboratory reference only.::::::NAD+ is a critical coenzyme found in all living cells, serving as an electron carrier in cellular respiration and a substrate for sirtuins and PARPs. Research spans aging biology, DNA repair, mitochondrial function, and neurodegeneration.::::::Canto et al., 2015, Cell Metabolism.::::::1812448::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDgucGRm||||||1000mg::::::Literature-based research context for laboratory reference only.::::::NAD+ is a critical coenzyme found in all living cells, serving as an electron carrier in cellular respiration and a substrate for sirtuins and PARPs. Research spans aging biology, DNA repair, mitochondrial function, and neurodegeneration.::::::Canto et al., 2015, Cell Metabolism.::::::1812449::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NDkucGRm

Lot Number

Product Name

GHK-CU

CAS#:89030-95-5

Sizes Select one specification

50mg::::::Literature-based research context for laboratory reference only.::::::GHK-Cu (Copper Peptide) is a naturally occurring tripeptide-copper complex first isolated by Loren Pickart in 1973. Research has examined its roles in wound healing, collagen and elastin synthesis, angiogenesis, and antioxidant gene expression regulation.::::::Pickart and Thaler, 1973, Nature New Biology.
~Pickart and Margolina, 2018, BioMed Research International.::::::1812450::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTAucGRm||||||100mg::::::Literature-based research context for laboratory reference only.::::::GHK-Cu (Copper Peptide) is a naturally occurring tripeptide-copper complex first isolated by Loren Pickart in 1973. Research has examined its roles in wound healing, collagen and elastin synthesis, angiogenesis, and antioxidant gene expression regulation.::::::Pickart and Thaler, 1973, Nature New Biology.
~Pickart and Margolina, 2018, BioMed Research International.::::::1812451::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTEucGRm

Lot Number

Product Name

MOTS-C

CAS#:1627580-64-6

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::MOTS-c is a 16-amino-acid peptide encoded in the 12S rRNA gene of the mitochondrial genome. Discovered in 2015, it acts as a mitochondrial-derived peptide that regulates nuclear gene expression, insulin sensitivity, and metabolic homeostasis.::::::Lee et al., 2015, Cell Metabolism.::::::1812452::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTIucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::MOTS-c is a 16-amino-acid peptide encoded in the 12S rRNA gene of the mitochondrial genome. Discovered in 2015, it acts as a mitochondrial-derived peptide that regulates nuclear gene expression, insulin sensitivity, and metabolic homeostasis.::::::Lee et al., 2015, Cell Metabolism.::::::1812453::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTMucGRm||||||40mg::::::Literature-based research context for laboratory reference only.::::::MOTS-c is a 16-amino-acid peptide encoded in the 12S rRNA gene of the mitochondrial genome. Discovered in 2015, it acts as a mitochondrial-derived peptide that regulates nuclear gene expression, insulin sensitivity, and metabolic homeostasis.::::::Lee et al., 2015, Cell Metabolism.::::::1812367~1812454::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTIzNjcucGRm~https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTQucGRm

Lot Number

Product Name

B12

CAS#:68-19-9

Sizes Select one specification

Lot Number

Product Name

melatonin

CAS#:73-31-4

Sizes Select one specification

Lot Number

Product Name

HCG

CAS#:9002-61-3

Sizes Select one specification

Lot Number

Product Name

5-Amino-1MQ

CAS#:42464-96-0

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Research has shown it can raise NAD+ levels and activate SIRT1, with studies focusing on metabolic regulation, adipogenesis inhibition, and energy expenditure.::::::Neelakantan et al., 2018, Biochemical Pharmacology.
~Iyamu and Huang, 2021, RSC Medicinal Chemistry.::::::1812459::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NTkucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Research has shown it can raise NAD+ levels and activate SIRT1, with studies focusing on metabolic regulation, adipogenesis inhibition, and energy expenditure.::::::Neelakantan et al., 2018, Biochemical Pharmacology.
~Iyamu and Huang, 2021, RSC Medicinal Chemistry.::::::1812460::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjAucGRm||||||50mg::::::Literature-based research context for laboratory reference only.::::::5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Research has shown it can raise NAD+ levels and activate SIRT1, with studies focusing on metabolic regulation, adipogenesis inhibition, and energy expenditure.::::::Neelakantan et al., 2018, Biochemical Pharmacology.
~Iyamu and Huang, 2021, RSC Medicinal Chemistry.::::::1812461::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjEucGRm

Lot Number

Product Name

GHRP-2 Acetate

CAS#:158861-67-7

Sizes Select one specification

Lot Number

Product Name

GHRP-6 Acetate

CAS#:87616-84-0

Sizes Select one specification

Lot Number

Product Name

Thymosin Alpha-1

CAS#:6234-98-6

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 by Allan Goldstein in the 1970s. Research focuses on dendritic cell maturation, T-cell differentiation, and innate immune potentiation in infectious disease models.::::::Goldstein et al., 1977, Proceedings of the National Academy of Sciences.::::::1812466::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjYucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 by Allan Goldstein in the 1970s. Research focuses on dendritic cell maturation, T-cell differentiation, and innate immune potentiation in infectious disease models.::::::Goldstein et al., 1977, Proceedings of the National Academy of Sciences.::::::1812467::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjcucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 by Allan Goldstein in the 1970s. Research focuses on dendritic cell maturation, T-cell differentiation, and innate immune potentiation in infectious disease models.::::::Goldstein et al., 1977, Proceedings of the National Academy of Sciences.::::::1812468::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjgucGRm

Lot Number

Product Name

Mazdutide

CAS#:3037634-25-3

Sizes Select one specification

5mg::::::Literature-based research context for laboratory reference only.::::::Mazdutide (IBI362) is a GLP-1/glucagon dual receptor agonist. Research investigates its balanced incretin and glucagonergic effects on body weight reduction and hepatic lipid metabolism, with particular interest in NAFLD/NASH models.::::::Ji et al., 2023, Nature Communications.::::::1812469::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NjkucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Mazdutide (IBI362) is a GLP-1/glucagon dual receptor agonist. Research investigates its balanced incretin and glucagonergic effects on body weight reduction and hepatic lipid metabolism, with particular interest in NAFLD/NASH models.::::::Ji et al., 2023, Nature Communications.::::::1812470::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzAucGRm||||||20mg::::::Literature-based research context for laboratory reference only.::::::Mazdutide (IBI362) is a GLP-1/glucagon dual receptor agonist. Research investigates its balanced incretin and glucagonergic effects on body weight reduction and hepatic lipid metabolism, with particular interest in NAFLD/NASH models.::::::Ji et al., 2023, Nature Communications.::::::1812471::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzEucGRm

Lot Number

Product Name

Survodutide

CAS#:2381089-84-3

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist. Research examines its ability to harness glucagon's lipolytic effects alongside GLP-1-mediated insulin secretion, exploring applications in obesity and metabolic liver disease.::::::Funakoshi et al., 2024, New England Journal of Medicine.::::::1812472::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzIucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist. Research examines its ability to harness glucagon's lipolytic effects alongside GLP-1-mediated insulin secretion, exploring applications in obesity and metabolic liver disease.::::::Funakoshi et al., 2024, New England Journal of Medicine.::::::1812473::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzMucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist. Research examines its ability to harness glucagon's lipolytic effects alongside GLP-1-mediated insulin secretion, exploring applications in obesity and metabolic liver disease.::::::Funakoshi et al., 2024, New England Journal of Medicine.::::::1812474::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzQucGRm

Lot Number

Product Name

DSIP

CAS#:62568-57-4

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Delta Sleep-Inducing Peptide (DSIP) is a nine-residue neuropeptide discovered by Marcel Monnier in 1977. Research has explored its roles in sleep architecture modulation, stress-axis regulation, and antioxidant enzyme induction.::::::Schoenenberger and Monnier, 1977, Proceedings of the National Academy of Sciences.::::::1812475::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzUucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Delta Sleep-Inducing Peptide (DSIP) is a nine-residue neuropeptide discovered by Marcel Monnier in 1977. Research has explored its roles in sleep architecture modulation, stress-axis regulation, and antioxidant enzyme induction.::::::Schoenenberger and Monnier, 1977, Proceedings of the National Academy of Sciences.::::::1812476::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzYucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Delta Sleep-Inducing Peptide (DSIP) is a nine-residue neuropeptide discovered by Marcel Monnier in 1977. Research has explored its roles in sleep architecture modulation, stress-axis regulation, and antioxidant enzyme induction.::::::Schoenenberger and Monnier, 1977, Proceedings of the National Academy of Sciences.::::::1812477::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzcucGRm||||||12mg::::::Literature-based research context for laboratory reference only.::::::Delta Sleep-Inducing Peptide (DSIP) is a nine-residue neuropeptide discovered by Marcel Monnier in 1977. Research has explored its roles in sleep architecture modulation, stress-axis regulation, and antioxidant enzyme induction.::::::Schoenenberger and Monnier, 1977, Proceedings of the National Academy of Sciences.::::::1812478::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzgucGRm

Lot Number

Product Name

Oxytocin Acetate

CAS#:50-56-6

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Oxytocin is a nine-amino-acid neuropeptide synthesized in the hypothalamus. Research examines its roles in social affiliation, stress-axis modulation via HPA axis interactions, uterine contractility, and cardiovascular regulation.::::::Gimpl and Fahrenholz, 2001, Physiological Reviews.::::::1812479::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0NzkucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Oxytocin is a nine-amino-acid neuropeptide synthesized in the hypothalamus. Research examines its roles in social affiliation, stress-axis modulation via HPA axis interactions, uterine contractility, and cardiovascular regulation.::::::Gimpl and Fahrenholz, 2001, Physiological Reviews.::::::1812480::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODAucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::Oxytocin is a nine-amino-acid neuropeptide synthesized in the hypothalamus. Research examines its roles in social affiliation, stress-axis modulation via HPA axis interactions, uterine contractility, and cardiovascular regulation.::::::Gimpl and Fahrenholz, 2001, Physiological Reviews.::::::1812481::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODEucGRm

Lot Number

Product Name

Hexarelin Acetate

CAS#:140703-51-1

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Hexarelin is a synthetic hexapeptide GH secretagogue that activates both GHSR-1a and the CD36 receptor on cardiomyocytes. Research has examined direct cardioprotective effects via CD36-mediated pathways relevant to myocardial protection models.::::::Bodart et al., 2002, Circulation Research.
~Xu et al., 2014, Pharmacological Research.::::::1812482::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODIucGRm||||||5mg::::::Literature-based research context for laboratory reference only.::::::Hexarelin is a synthetic hexapeptide GH secretagogue that activates both GHSR-1a and the CD36 receptor on cardiomyocytes. Research has examined direct cardioprotective effects via CD36-mediated pathways relevant to myocardial protection models.::::::Bodart et al., 2002, Circulation Research.
~Xu et al., 2014, Pharmacological Research.::::::1812483::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODMucGRm

Lot Number

Product Name

Adipotide

CAS#:140703-51-1

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::Adipotide (FTPP) is a pro-apoptotic peptidomimetic that selectively targets the vasculature of white adipose tissue by binding prohibitin on adipose endothelial cells. Research investigates selective ablation of fat-feeding vessels as a model for targeted adipose reduction.::::::Kolonin et al., 2004, Nature Medicine.
~Barnhart et al., 2011, Science Translational Medicine.::::::1812484::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODQucGRm||||||5mg::::::::::::Adipotide (FTPP) is a pro-apoptotic peptidomimetic that selectively targets the vasculature of white adipose tissue by binding prohibitin on adipose endothelial cells. Research investigates selective ablation of fat-feeding vessels as a model for targeted adipose reduction.::::::Kolonin et al., 2004, Nature Medicine.
~Barnhart et al., 2011, Science Translational Medicine.::::::1812485::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0ODUucGRm

Lot Number

Product Name

PEG MGF

CAS#:140417-29-5

Sizes Select one specification

Lot Number

Product Name

IGF-DES

CAS#:124431-57-3

Sizes Select one specification

Lot Number

Product Name

Thymalin

CAS#:83089-70-7

Sizes Select one specification

Lot Number

Product Name

Gonadorelin

CAS#:33384-29-7

Sizes Select one specification

Lot Number

Product Name

HMG

CAS#:9002-61-7

Sizes Select one specification

Lot Number

Product Name

Cagrilintide + Semaglutide

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number

Product Name

ACE-031

CAS#:879685-55-2

Sizes Select one specification

Lot Number

Product Name

AICAR

CAS#:2627-69-2

Sizes Select one specification

Lot Number

Product Name

SLU-PP-332

CAS#:3037305-03-0

Sizes Select one specification

Lot Number

Product Name

AHK-CU

CAS#:682809-81-0

Sizes Select one specification

50mg::::::Literature-based research context for laboratory reference only.::::::AHK-CU is a synthetic copper-binding tripeptide (L-alanyl-L-histidyl-L-lysine-Cu2+) designed to study hair follicle biology and dermal remodeling. Preclinical research indicates it promotes dermal papilla cell proliferation and stimulates vascular endothelial growth factor (VEGF) expression to enhance microvascular networks.::::::Pyo et al., 2007, Archives of Pharmacal Research.::::::1812497::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0OTcucGRm||||||100mg::::::Literature-based research context for laboratory reference only.::::::AHK-CU is a synthetic copper-binding tripeptide (L-alanyl-L-histidyl-L-lysine-Cu2+) designed to study hair follicle biology and dermal remodeling. Preclinical research indicates it promotes dermal papilla cell proliferation and stimulates vascular endothelial growth factor (VEGF) expression to enhance microvascular networks.::::::Pyo et al., 2007, Archives of Pharmacal Research.::::::1812498::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0OTgucGRm

Lot Number

Product Name

FOX04-DRI

CAS#:2460055-10-9

Sizes Select one specification

2mg::::::Literature-based research context for laboratory reference only.::::::FOX04-DRI is a cell-permeable D-retro-inverso peptide designed to act as a senolytic agent by disrupting the interaction between FOXO4 and p53. In preclinical models of aging and chemotoxicity, selective disruption of this complex enables p53 to initiate cell-intrinsic apoptosis in senescent cells while leaving healthy cells unaffected, helping restore tissue homeostasis.::::::Baar et al., 2017, Cell.::::::1812499::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI0OTkucGRm||||||10mg::::::Literature-based research context for laboratory reference only.::::::FOX04-DRI is a cell-permeable D-retro-inverso peptide designed to act as a senolytic agent by disrupting the interaction between FOXO4 and p53. In preclinical models of aging and chemotoxicity, selective disruption of this complex enables p53 to initiate cell-intrinsic apoptosis in senescent cells while leaving healthy cells unaffected, helping restore tissue homeostasis.::::::Baar et al., 2017, Cell.::::::1812500::::::https://brown-biology.com/pdf-viewer.html?token=L3BkZi9jb2EvMjYwODAwLzE4MTI1MDAucGRm

Lot Number

Product Name

Lipo-c

CAS#:Proprietary Blend

Sizes Select one specification

Lot Number